These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2455916)

  • 1. Interactions of bacterial lipopolysaccharides with serum proteins.
    Ulevitch RJ; Tobias PS
    Prog Clin Biol Res; 1988; 272():309-18. PubMed ID: 2455916
    [No Abstract]   [Full Text] [Related]  

  • 2. Endotoxin interactions with serum proteins relationship to biological activity.
    Tesh VL; Vukajlovich SW; Morrison DC
    Prog Clin Biol Res; 1988; 272():47-62. PubMed ID: 3393572
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel acute phase marker in cattle: lipopolysaccharide binding protein (LBP).
    Schroedl W; Fuerll B; Reinhold P; Krueger M; Schuett C
    J Endotoxin Res; 2001; 7(1):49-52. PubMed ID: 11521082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin.
    González-Navajas JM; Bellot P; Francés R; Zapater P; Muñoz C; García-Pagán JC; Pascual S; Pérez-Mateo M; Bosch J; Such J
    J Hepatol; 2008 Jan; 48(1):61-7. PubMed ID: 17998145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the host response to bacterial lipopolysaccharides.
    Ulevitch RJ; Tobias PS; Mathison JC
    Fed Proc; 1984 Sep; 43(12):2755-9. PubMed ID: 6468671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins.
    Kitchens RL; Thompson PA
    J Endotoxin Res; 2003; 9(2):113-8. PubMed ID: 12803885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
    Wurfel MM; Wright SD
    Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s).
    Tobias PS; Ulevitch RJ
    J Immunol; 1983 Oct; 131(4):1913-6. PubMed ID: 6311900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
    Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C
    Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
    Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
    J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of lipopolysaccharide with macrophages.
    Manthey CL; Vogel SN
    Immunol Ser; 1994; 60():63-81. PubMed ID: 7504530
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipopolysaccharide binding by plasma proteins: an important protective effect?
    Holland P; Hodge D
    Crit Care Med; 2005 Jul; 33(7):1664-6. PubMed ID: 16003091
    [No Abstract]   [Full Text] [Related]  

  • 13. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of bacterial lipopolysaccharides with tissue macrophages and plasma lipoproteins.
    Maier RV; Mathison JC; Ulevitch RJ
    Prog Clin Biol Res; 1981; 62():133-55. PubMed ID: 7025010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum modulation of neutrophil response to Porphyromonas gingivalis LPS in periodontal disease.
    Soolari AS; Champagne C; Punzi JS; Amar S; Van Dyke TE
    J Int Acad Periodontol; 1999 Oct; 1(4):101-9. PubMed ID: 12666954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria.
    Lengacher S; Jongeneel CV; Le Roy D; Lee JD; Kravchenko V; Ulevitch RJ; Glauser MP; Heumann D
    J Inflamm; 1995-1996; 47(4):165-72. PubMed ID: 9144073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of porcine ficolin-alpha to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria.
    Nahid AM; Sugii S
    Dev Comp Immunol; 2006; 30(3):335-43. PubMed ID: 15964070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
    Kitchens RL; Thompson PA
    J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-LPS targets and actions of LPS binding protein (LBP).
    Schröder NW; Schumann RR
    J Endotoxin Res; 2005; 11(4):237-42. PubMed ID: 16176661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.